These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33509693)

  • 21. Risk of invasive Haemophilus influenzae type b (Hib) disease in adults with secondary immunodeficiency in the post-Hib vaccine era.
    Nix EB; Hawdon N; Gravelle S; Biman B; Brigden M; Malik S; McCready W; Ferroni G; Ulanova M
    Clin Vaccine Immunol; 2012 May; 19(5):766-71. PubMed ID: 22398246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating innate and adaptive immunity against anti-Haemophilus influenzae type b.
    Zarei AE; Linjawi MH; Redwan EM
    Hum Antibodies; 2019; 27(3):201-212. PubMed ID: 30958343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement component 3 binding to Haemophilus influenzae type b in the presence of anticapsular and anti-outer membrane antibodies.
    Hetherington SV; Patrick CC
    Infect Immun; 1992 Jan; 60(1):19-24. PubMed ID: 1729183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemophilus influenzae type b capsular polysaccharide antibody levels in Japanese young patients with hematological malignancies and asplenia.
    Takeshita K; Ishiwada N; Takeuchi N; Takahashi Y; Fukasawa C; Hishiki H; Hoshino T; Shimojo N
    J Infect Chemother; 2020 Sep; 26(9):959-962. PubMed ID: 32402734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study.
    Nix EB; Choi J; Anthes C; Gaultier GN; Thorgrimson J; Cox AD; Tsang RSW; McCready WG; Boreham D; Ulanova M
    PLoS One; 2018; 13(8):e0201282. PubMed ID: 30110339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
    Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
    Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular ontogeny of the human antibody repertoire to the Haemophilus influenzae type B polysaccharide: expression of canonical variable regions and their variants in vaccinated infants.
    Lucas AH; McLean GR; Reason DC; O'Connor AP; Felton MC; Moulton KD
    Clin Immunol; 2003 Aug; 108(2):119-27. PubMed ID: 12921758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation.
    Tarr PI; Hosea SW; Brown EJ; Schneerson R; Sutton A; Frank MM
    J Immunol; 1982 Apr; 128(4):1772-5. PubMed ID: 6977569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low concentrations of immunoglobulin G antibodies to Salmonella serogroup C in C2 deficiency: suggestion of a mannan-binding lectin pathway-dependent mechanism.
    Selander B; Weintraub A; Holmström E; Sturfelt G; Truedsson L; Mårtensson U; Jensenius JC; Sjöholm AG
    Scand J Immunol; 1999 Dec; 50(6):555-61. PubMed ID: 10607303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune response of premature infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae type b conjugate vaccines.
    Slack MH; Schapira D; Thwaites RJ; Burrage M; Southern J; Andrews N; Borrow R; Goldblatt D; Miller E
    J Infect Dis; 2001 Dec; 184(12):1617-20. PubMed ID: 11740740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity, reactogenicity, and immune memory after primary vaccination with a novel Haemophilus influenzae-Neisseria meningitidis serogroup C conjugate vaccine.
    Schmitt HJ; Maechler G; Habermehl P; Knuf M; Saenger R; Begg N; Boutriau D
    Clin Vaccine Immunol; 2007 Apr; 14(4):426-34. PubMed ID: 17287313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vaccinated individuals serum bactericidal activity against B meningococci is abrogated by C5 inhibition but not by inhibition of the alternative complement pathway.
    Ispasanie E; Muri L; Schmid M; Schubart A; Thorburn C; Zamurovic N; Holbro T; Kammüller M; Pluschke G
    Front Immunol; 2023; 14():1180833. PubMed ID: 37457736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
    J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invasive Haemophilus influenzae type b (Hib) infection in an adult patient with a selective deficiency of antibody to the Hib capsular polysaccharide.
    Follin P; Ulanova M; Hahn-Zoric M; Hanson LA
    Clin Infect Dis; 1997 Oct; 25(4):915-7. PubMed ID: 9356808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemophilus influenzae serotype b seroprevalence in central Lao PDR before and after vaccine introduction.
    Hefele L; Lai J; Vilivong K; Bounkhoun T; Chanthaluanglath V; Chanthongthip A; Balloch A; Black AP; Hübschen JM; Russell FM; Muller CP
    PLoS One; 2022; 17(9):e0274558. PubMed ID: 36107979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concentration and avidity of anti-Haemophilus influenzae type b (Hib) antibodies in serum samples obtained from patients for whom Hib vaccination failed.
    Breukels MA; Jol-van der Zijde E; van Tol MJ; Rijkers GT
    Clin Infect Dis; 2002 Jan; 34(2):191-7. PubMed ID: 11740707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccine.
    Barbour ML; Booy R; Crook DW; Griffiths H; Chapel HM; Moxon ER; Mayon-White D
    Pediatr Infect Dis J; 1993 Jun; 12(6):478-84. PubMed ID: 8345980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines.
    Kauppi M; Eskola J; Käyhty H
    Pediatr Infect Dis J; 1995 Apr; 14(4):286-94. PubMed ID: 7603810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional characterization of human IgG, IgM, and IgA antibody directed to the capsule of Haemophilus influenzae type b.
    Schreiber JR; Barrus V; Cates KL; Siber GR
    J Infect Dis; 1986 Jan; 153(1):8-16. PubMed ID: 3484506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemophilus influenzae type b disease: impact and effectiveness of diphtheria-tetanus toxoids-acellular pertussis (-inactivated poliovirus)/H. influenzae type b combination vaccines.
    Schmitt HJ; von Kries R; Hassenpflug B; Hermann M; Siedler A; Niessing W; Clemens R; Weil J
    Pediatr Infect Dis J; 2001 Aug; 20(8):767-74. PubMed ID: 11734739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.